scholarly journals Effectiveness of COVID‐19 vaccination in patients after allogeneic haematopoietic cell transplant: how much protection are we getting?

2021 ◽  
Author(s):  
Salyka Sengsayadeth ◽  
Larisa Broglie ◽  
Bipin N. Savani
Keyword(s):  
Cell Transplant ◽  
Haematopoietic Cell

scholarly journals The Long Term Impact of Cytomegalovirus (CMV) Viremia on Quality of Life in Allogeneic Haematopoietic Cell Transplant Recipients (HCT)

2020 ◽  
Vol 26 (3) ◽  
pp. S359-S360
Author(s):  
Michelle Yong ◽  
Sonia Raj ◽  
Zhi Han Yeoh ◽  
Monica Anne Slavin ◽  
Yvonne Panek-Hudson ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Cell Transplant ◽  
Transplant Recipients ◽  
Haematopoietic Cell ◽  
Long Term Impact

Neutropenic diets to prevent cancer infections: updated systematic review and meta-analysis

2019 ◽  
pp. bmjspcare-2018-001742 ◽  
Author(s):  
Mohamad Bassam Sonbol ◽  
Tania Jain ◽  
Belal Firwana ◽  
Talal Hilal ◽  
Thomas Deleon ◽  
...  
Keyword(s):  
Systematic Review ◽  
Meta Analysis ◽  
Cell Transplant ◽  
Regular Diet ◽  
Patients With Cancer ◽  
Transplant Patients ◽  
Haematopoietic Cell ◽  
Significant Difference ◽  
Neutropenic Patients ◽  
Meta Analyses

IntroductionMultiple studies have questioned the benefit of neutropenic diets in decreasing infections in patients with cancer, but recent surveys showed that such diets are still prescribed. In this study, we sought to evaluate the effectiveness of neutropenic diet in decreasing infection and mortality in neutropenic patients with cancer with neutropenia. This review is an update of a previously published systematic review.Materials and methodsWe searched different databases to identify comparative studies that investigated the effect of neutropenic diet compared with regular diet in neutropenic adults and children with cancer. We conducted random‐effects meta‐analyses using the Der‐Simonian and Laird method to pool treatment effects from included studies. Outcomes of interest were mortality, bacteremia/fungemia, major infections, quality of life, and the composite outcome for neutropenic fever and/or infection.ResultsWe included six studies (five randomised) with 1116 patients, with 772 (69.1%) having underwent haematopoietic cell transplant. There was no statistically significant difference between neutropenic diet and regular diet in the rates of major infections (relative risk [RR] 1.16; 95% CI 0.94 to 1.42) or bacteremia/fungemia (RR 0.96; 95% CI 0.60 to 1.53). In haematopoietic cell transplant patients, neutropenic diet was associated with a slightly higher risk of infections (RR 1.25; 95% CI 1.02 to 1.54). No difference in mortality was seen between neutropenic diet and regular diet (RR 1.08, 95% CI 0.78 to 1.50).ConclusionThere is currently no evidence to support the use of neutropenic diet or other food restrictions in neutropenic patients with cancer. Patients and clinicians should continue to follow the safe food-handling guidelines as recommended by the U.S. Food and Drug Administration.

Toxoplasma prophylaxis in haematopoietic cell transplant recipients

2015 ◽  
Vol 28 (4) ◽  
pp. 283-292 ◽  
Author(s):  
Kiran Gajurel ◽  
Reshika Dhakal ◽  
José G. Montoya
Keyword(s):  
Cell Transplant ◽  
Transplant Recipients ◽  
Haematopoietic Cell

JACIE recommendations for microbiological environmental surveillance in haematopoietic cell transplant units

2020 ◽  
Vol 106 (1) ◽  
pp. 196-197
Author(s):  
P. Saliou ◽  
J. Picard ◽  
G. Héry-Arnaud ◽  
C. Payan ◽  
G. Guillerm ◽  
...  
Keyword(s):  
Cell Transplant ◽  
Environmental Surveillance ◽  
Haematopoietic Cell
Sign in / Sign up

Export Citation Format

Share Document